Lucia Clara Orlandini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lucia Clara Orlandini has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
Jie Li
Department of Radiation Oncology, Presicion Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China
9 shared publicationsXianliang Wang
Department of Radiation Oncology, Presicion Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China
9 shared publicationsBin Tang
Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Affiliated Cancer Hospital of University and Electronic Science and Technology of China, Chengdu, China
8 shared publicationsXin Xin
Department of Radiation Oncology, Presicion Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China
8 shared publications- Bin Tang
Department of Radiation Oncology, Precision Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China
7 shared publications Feng Yang
Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Radiation Oncology Key Laboratory of Sichuan Province, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
7 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by Springer Nature in La radiologia medica
- Vol. 131 (4) , 669-679
Step-by-step assessment of MRI-only workflow in pelvic radiotherapy: feasibility and practical implementation
Purpose Magnetic resonance imaging-only (MRI-only) radiotherapy workflow capitalizes on the superior soft tissue contrast of MRI while eliminating computed tomography-MRI (CT-MRI) registration uncertainties. Most existing studies focus on optimizing individual components of this workflow, i.e., synthetic CT (sCT) generation, dose calculation accuracy, and the reliability of MRI-based patient positioning, while often neglecting comprehensive evaluation of the whole clinical process and its interdependent technical requirements. Methods A total of 55 pelvic cancer patients, who underwent the standard radiotherapy workflow based on CT-MRI co-registration and involving a variety of imaging scanners, treatment planning systems (TPSs), and linear accelerators (LINACs), were included. For each patient, a fully integrated MRI-only approach was developed through a step-by-step evaluation of the different radiotherapy phases, including MRI-alone delineation, sCT generation with dose calculation, and cone beam CT-MRI (CBCT-MRI)-guided positioning. Comparative evaluations with the standard workflow were performed for target segmentation (dice similarity coefficient [DSC] and Hausdorff distance [HD]), dose calculation (DVH parameters and gamma analysis), and daily patient positioning (CBCT-CT versus CBCT-MRI registrations). Results The proposed MRI-only workflow is applicable throughout all radiotherapy phases and compatible across multiple imaging systems, treatment planning systems, and linear accelerators. MRI-only delineation showed excellent agreement for the prostate (DSC = 0.948 ± 0.028) and cervix (DSC = 0.940 ± 0.015), whereas contour agreement for the rectum and prostate bed (DSC = 0.696 ± 0.037 and 0.689 ± 0.047, respectively) fell within the range of inter-observer variability. Dosimetric comparisons revealed no significant differences between CT- and sCT-based plans (p > 0.05), with median gamma pass rates of 99.0% and 97.9% for the whole body using 3%/3 mm and 2%/2 mm criteria, respectively. CBCT-MRI registration indicated positioning errors comparable to CBCT-CT. Conclusion MRI-only pelvic radiotherapy workflows are clinically feasible through customized protocols for target and OAR segmentation, MRI scanner setup and immobilization, sequence selection, sCT-based dose calculation validation, and CBCT-MRI matching reliability.
- 2 December 2025
- Published by Springer Nature in La radiologia medica
- Vol. 131 (4) , 669-679
Open AccessStep-by-step assessment of MRI-only workflow in pelvic radiotherapy: feasibility and practical implementation
Purpose Magnetic resonance imaging-only (MRI-only) radiotherapy workflow capitalizes on the superior soft tissue contrast of MRI while eliminating computed tomography-MRI (CT-MRI) registration uncertainties. Most existing studies focus on optimizing individual components of this workflow, i.e., synthetic CT (sCT) generation, dose calculation accuracy, and the reliability of MRI-based patient positioning, while often neglecting comprehensive evaluation of the whole clinical process and its interdependent technical requirements. Methods A total of 55 pelvic cancer patients, who underwent the standard radiotherapy workflow based on CT-MRI co-registration and involving a variety of imaging scanners, treatment planning systems (TPSs), and linear accelerators (LINACs), were included. For each patient, a fully integrated MRI-only approach was developed through a step-by-step evaluation of the different radiotherapy phases, including MRI-alone delineation, sCT generation with dose calculation, and cone beam CT-MRI (CBCT-MRI)-guided positioning. Comparative evaluations with the standard workflow were performed for target segmentation (dice similarity coefficient [DSC] and Hausdorff distance [HD]), dose calculation (DVH parameters and gamma analysis), and daily patient positioning (CBCT-CT versus CBCT-MRI registrations). Results The proposed MRI-only workflow is applicable throughout all radiotherapy phases and compatible across multiple imaging systems, treatment planning systems, and linear accelerators. MRI-only delineation showed excellent agreement for the prostate (DSC = 0.948 ± 0.028) and cervix (DSC = 0.940 ± 0.015), whereas contour agreement for the rectum and prostate bed (DSC = 0.696 ± 0.037 and 0.689 ± 0.047, respectively) fell within the range of inter-observer variability. Dosimetric comparisons revealed no significant differences between CT- and sCT-based plans (p > 0.05), with median gamma pass rates of 99.0% and 97.9% for the whole body using 3%/3 mm and 2%/2 mm criteria, respectively. CBCT-MRI registration indicated positioning errors comparable to CBCT-CT. Conclusion MRI-only pelvic radiotherapy workflows are clinically feasible through customized protocols for target and OAR segmentation, MRI scanner setup and immobilization, sequence selection, sCT-based dose calculation validation, and CBCT-MRI matching reliability.
- 27 September 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 123 (1) , e129
Feasibility Study of Functional MR Imaging Based Biologically Guided Lattice Radiotherapy
- 27 September 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 123 (1) , e129
Feasibility Study of Functional MR Imaging Based Biologically Guided Lattice Radiotherapy
- 27 September 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 123 (1) , e130-e131
Feasibility and Accuracy of CBCT-MRI Image Matching for Daily Positioning in MRI-Only Pelvic Radiotherapy
- 27 September 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 123 (1) , e130-e131
Feasibility and Accuracy of CBCT-MRI Image Matching for Daily Positioning in MRI-Only Pelvic Radiotherapy
- Open Access
- 25 July 2025
- Published by Springer Nature in Radiation Oncology
- Vol. 20 (1) , 117
Early prediction of parotid glands secretory function based on ADC variations during radiotherapy for nasopharyngeal carcinoma: a phase II prospective study
This study aimed to quantify dynamic changes in the Apparent Diffusion Coefficient (ADC) values of the parotid glands during radiotherapy and explore their correlation with early-stage gland dysfunction. Nasopharyngeal carcinoma patients receiving definitive chemoradiotherapy were prospectively enrolled. Magnetic Resonance Diffusion-Weighted Imaging (MR-DWI) was performed at pre-radiotherapy (pre-RT), the 5th, 15th fractions, and end of radiotherapy. ADC values and volumes for ipsilateral (IP) and contralateral parotid glands (CP) were recorded. Salivary function was assessed using scintigraphy (SGS) and the Radiation Therapy Oncology Group (RTOG) xerostomia criteria. A total of 80 eligible patients were analyzed. From pre-radiotherapy(pre-RT) to the end of radiotherapy, Pearson correlation analysis showed that changes in ADC values were positively correlated with the delivered dose (p < 0.01) and reduction in parotid volume (p < 0.01).From pre-RT to the 5th fraction, mean ADC values((ΔADC5) increased significantly by 17.7% (IP) and 16.3% (CP) (p < 0.01), with minimal volume changes(ΔrV5) (p = 0.060, p = 0.068). Spearman analysis revealed a positive association between the change in ΔADC5 and the incidence of xerostomia 6 months after radiotherapy (p < 0.01). Multivariable analysis identified ΔADC5 rather than ΔrV5 as an independent predictor of secretory dysfunction (IP: Odds Ratio (OR) = 1.010, p = 0.015 by SGS; OR = 1.026, p = 0.000 by RTOG; CP: OR = 1.017, p = 0.004 by SGS; OR = 1.015, p = 0.002 by RTOG). This study analyze the dynamic changes in parotid gland ADC values, volume, and secretion function throughout radiotherapy. Changes in ΔADC5 can predict radiation-induced parotid gland injury before significant volume changes occur, thereby enabling early intervention.
- 25 July 2025
- Published by Springer Nature in Radiation Oncology
- Vol. 20 (1) , 117
Open AccessEarly prediction of parotid glands secretory function based on ADC variations during radiotherapy for nasopharyngeal carcinoma: a phase II prospective study
This study aimed to quantify dynamic changes in the Apparent Diffusion Coefficient (ADC) values of the parotid glands during radiotherapy and explore their correlation with early-stage gland dysfunction. Nasopharyngeal carcinoma patients receiving definitive chemoradiotherapy were prospectively enrolled. Magnetic Resonance Diffusion-Weighted Imaging (MR-DWI) was performed at pre-radiotherapy (pre-RT), the 5th, 15th fractions, and end of radiotherapy. ADC values and volumes for ipsilateral (IP) and contralateral parotid glands (CP) were recorded. Salivary function was assessed using scintigraphy (SGS) and the Radiation Therapy Oncology Group (RTOG) xerostomia criteria. A total of 80 eligible patients were analyzed. From pre-radiotherapy(pre-RT) to the end of radiotherapy, Pearson correlation analysis showed that changes in ADC values were positively correlated with the delivered dose (p < 0.01) and reduction in parotid volume (p < 0.01).From pre-RT to the 5th fraction, mean ADC values((ΔADC5) increased significantly by 17.7% (IP) and 16.3% (CP) (p < 0.01), with minimal volume changes(ΔrV5) (p = 0.060, p = 0.068). Spearman analysis revealed a positive association between the change in ΔADC5 and the incidence of xerostomia 6 months after radiotherapy (p < 0.01). Multivariable analysis identified ΔADC5 rather than ΔrV5 as an independent predictor of secretory dysfunction (IP: Odds Ratio (OR) = 1.010, p = 0.015 by SGS; OR = 1.026, p = 0.000 by RTOG; CP: OR = 1.017, p = 0.004 by SGS; OR = 1.015, p = 0.002 by RTOG). This study analyze the dynamic changes in parotid gland ADC values, volume, and secretion function throughout radiotherapy. Changes in ΔADC5 can predict radiation-induced parotid gland injury before significant volume changes occur, thereby enabling early intervention.
- Open Access
- 21 July 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1580513
Proton minibeam radiotherapy: a review
Radiotherapy plays a crucial role in cancer treatment. Spatially fractionated radiotherapy (SFRT) has garnered significant interest as a therapeutic strategy that delivers alternating regions of high and low radiation doses, thereby optimizing the therapeutic ratio by minimizing damage to adjacent normal tissues while achieving tumoricidal effects. Proton minibeam radiotherapy (pMBRT), a cutting-edge iteration within the SFRT paradigm, has attracted considerable attention owing to its purported benefits in dose distribution optimization, enhanced tumor control, and superior preservation of normal tissue. This manuscript presents an extensive evaluation of different applications of pMBRT, with a focus on the outcomes observed in preclinical research studies. Additionally, we explored the challenges faced in translating pMBRT from research to clinical practice, while also highlighting the significant potential this technique holds for the future of cancer treatment.
- 21 July 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1580513
Open AccessProton minibeam radiotherapy: a review
Radiotherapy plays a crucial role in cancer treatment. Spatially fractionated radiotherapy (SFRT) has garnered significant interest as a therapeutic strategy that delivers alternating regions of high and low radiation doses, thereby optimizing the therapeutic ratio by minimizing damage to adjacent normal tissues while achieving tumoricidal effects. Proton minibeam radiotherapy (pMBRT), a cutting-edge iteration within the SFRT paradigm, has attracted considerable attention owing to its purported benefits in dose distribution optimization, enhanced tumor control, and superior preservation of normal tissue. This manuscript presents an extensive evaluation of different applications of pMBRT, with a focus on the outcomes observed in preclinical research studies. Additionally, we explored the challenges faced in translating pMBRT from research to clinical practice, while also highlighting the significant potential this technique holds for the future of cancer treatment.
- Open Access
- 1 July 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-12
Steps towards overcoming challenges in clinical practice at 1.5T MR-Linac for lung cancer adaptive radiotherapy
The MR-guided adaptive radiotherapy (MRgART) workflow at the 1.5 T Unity MR-Linac relies on synthetic CT (sCT) generated through bulk density assignment. Although sCT-based dose calculations are the standard approach, it is well known that their accuracy can be compromised in lung tumors due to the high dose gradients surrounding the targets. This study investigates clinical cases to determine whether these challenges affect all lung targets or if, for a subset partially located in high-density dose regions, the sCT calculations performed in the Unity clinical workflow are sufficiently accurate, supporting their routine clinical application. Forty-eight lung cancer patients undergoing stereotactic body radiotherapy at Unity MR-Linac, were included in this study. Patients were stratified into two groups based on target position: $$\:{\text{G}}_{\text{A}\text{T}\text{M}}$$ group including targets attached to thoracic wall or mediastinum, and $$\:{\text{G}}_{\text{I}\text{P}\text{T}}$$ (group isolated pulmonary target), including targets entirely within the lung parenchyma and surrounded by air-filled lung tissue. The reference treatment plans ( $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ ) were optimised on the simulation CT using inverse-planning intensity modulated radiation therapy (IMRT) with the Monaco treatment planning system to deliver 50 Gy in 5 fractions. $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ included all contour information needed to generate the sCT through bulk electron density assignment, the standard procedure for Unity MR-Linac. To evaluate the dosimetric accuracy of sCT-based dose calculations, a second plan ( $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ ) was created by recalculating $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ on the sCT derived from the reference CT. The sCT was generated using the MRgART routine, which assigns mean ED values to all contoured structures. Dose-volume histograms were compared between $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ and $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ for targets and organs at risk (OARs), with additional evaluation of tumor control probability, and normal tissue complication probability. Dose distributions were further evaluated using global gamma analysis with 3%/3 mm and 2%/2 mm criteria. Significant differences (p < 0.05) in key dosimetric parameters ( $$\:{\text{V}}_{50\text{G}\text{y}}$$ , $$\:{\text{V}}_{45\text{G}\text{y}}$$ , $$\:{\text{D}}_{50\text{\%}}$$ ) were observed between $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ and $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ in the $$\:{\text{G}}_{\text{I}\text{P}\text{T}}$$ group, with percentage differences reaching up to 3.49%. Conversely, in $$\:{\text{G}}_{\text{A}\text{T}\text{M}}$$ , percentage differences were less than 1% and not statistically significant (p > 0.05). For OARs, no significant differences (p > 0.05) were observed in either group, except for the lungs minus the gross tumor volume (lungs-GTV), where percentage differences remained below 1.5%. Radiobiological modelling yielded consistent results, confirming the dosimetric findings. Gamma analysis showed consistent dose distributions, with a global pass rate above 95% for 3%/3 mm criteria and above 90% for 2%/2 mm criteria. This study demonstrates that sCT-based dose calculations are feasible and reliable for pulmonary targets attached to the thoracic wall or mediastinum, supporting their routine integration into MRgART workflows on the Unity MR-Linac. However, for isolated pulmonary targets, deviations should be considered when implementing sCT-based planning in clinical practice.- 1 July 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-12
Open AccessSteps towards overcoming challenges in clinical practice at 1.5T MR-Linac for lung cancer adaptive radiotherapy
The MR-guided adaptive radiotherapy (MRgART) workflow at the 1.5 T Unity MR-Linac relies on synthetic CT (sCT) generated through bulk density assignment. Although sCT-based dose calculations are the standard approach, it is well known that their accuracy can be compromised in lung tumors due to the high dose gradients surrounding the targets. This study investigates clinical cases to determine whether these challenges affect all lung targets or if, for a subset partially located in high-density dose regions, the sCT calculations performed in the Unity clinical workflow are sufficiently accurate, supporting their routine clinical application. Forty-eight lung cancer patients undergoing stereotactic body radiotherapy at Unity MR-Linac, were included in this study. Patients were stratified into two groups based on target position: $$\:{\text{G}}_{\text{A}\text{T}\text{M}}$$ group including targets attached to thoracic wall or mediastinum, and $$\:{\text{G}}_{\text{I}\text{P}\text{T}}$$ (group isolated pulmonary target), including targets entirely within the lung parenchyma and surrounded by air-filled lung tissue. The reference treatment plans ( $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ ) were optimised on the simulation CT using inverse-planning intensity modulated radiation therapy (IMRT) with the Monaco treatment planning system to deliver 50 Gy in 5 fractions. $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ included all contour information needed to generate the sCT through bulk electron density assignment, the standard procedure for Unity MR-Linac. To evaluate the dosimetric accuracy of sCT-based dose calculations, a second plan ( $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ ) was created by recalculating $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ on the sCT derived from the reference CT. The sCT was generated using the MRgART routine, which assigns mean ED values to all contoured structures. Dose-volume histograms were compared between $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ and $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ for targets and organs at risk (OARs), with additional evaluation of tumor control probability, and normal tissue complication probability. Dose distributions were further evaluated using global gamma analysis with 3%/3 mm and 2%/2 mm criteria. Significant differences (p < 0.05) in key dosimetric parameters ( $$\:{\text{V}}_{50\text{G}\text{y}}$$ , $$\:{\text{V}}_{45\text{G}\text{y}}$$ , $$\:{\text{D}}_{50\text{\%}}$$ ) were observed between $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ and $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ in the $$\:{\text{G}}_{\text{I}\text{P}\text{T}}$$ group, with percentage differences reaching up to 3.49%. Conversely, in $$\:{\text{G}}_{\text{A}\text{T}\text{M}}$$ , percentage differences were less than 1% and not statistically significant (p > 0.05). For OARs, no significant differences (p > 0.05) were observed in either group, except for the lungs minus the gross tumor volume (lungs-GTV), where percentage differences remained below 1.5%. Radiobiological modelling yielded consistent results, confirming the dosimetric findings. Gamma analysis showed consistent dose distributions, with a global pass rate above 95% for 3%/3 mm criteria and above 90% for 2%/2 mm criteria. This study demonstrates that sCT-based dose calculations are feasible and reliable for pulmonary targets attached to the thoracic wall or mediastinum, supporting their routine integration into MRgART workflows on the Unity MR-Linac. However, for isolated pulmonary targets, deviations should be considered when implementing sCT-based planning in clinical practice. - 21 May 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 206, S3328-S3329
3745 Refining bladder filling strategies in MR-guided adaptive radiotherapy for rectal cancer
- 21 May 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 206, S3328-S3329
3745 Refining bladder filling strategies in MR-guided adaptive radiotherapy for rectal cancer
- 21 May 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 206, S3036-S3038
3288 Step-by-step assessment of MRI-Only workflow in pelvic radiotherapy: feasibility and operational review
- 21 May 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 206, S3036-S3038
3288 Step-by-step assessment of MRI-Only workflow in pelvic radiotherapy: feasibility and operational review
- 21 May 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 206, S2863-S2864
3211 Study of biologically guided lattice spatially fractionated radiation therapy based on diffusion-weighted imaging
- 21 May 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 206, S2863-S2864
3211 Study of biologically guided lattice spatially fractionated radiation therapy based on diffusion-weighted imaging
- 21 May 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 206, S3233-S3234
1616 Reproducibility and stability of DIBH and free breath in breast radiotherapy based on real-time 3- dimensional optical surface imaging system
- 21 May 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 206, S3233-S3234
1616 Reproducibility and stability of DIBH and free breath in breast radiotherapy based on real-time 3- dimensional optical surface imaging system